Antibodies to amyloid beta

Published: 07/07/2025

However, overproduction or changes in Aβ levels are believed to be key events in the pathogenesis of sporadic and early onset AD. For this reason, A□ has become a major target for the development of drugs designed to reduce its formation (Vassar et al., 1999), or to activate mechanisms that …